Aemetis Inc (AMTX)
NASDAQMaterialsChemicals - SpecialtySnapshot 2026-09-04
$1.830.00%
Close 2026-09-04 · 1-day change
NASDAQMaterialsChemicals - SpecialtySnapshot 2026-09-04
QuarterlyIQ Insights · AMTX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 219.8 | 197.6 | 267.6 | 77.2 | 28.1 | 211.9 | 165.6 | 202.0 | 171.5 | 150.2 | 143.2 | 146.6 | 207.7 | 177.5 | 189.0 | 141.9 |
| Total Revenues | — | — | — | 77.2 | 28.1 | 211.9 | 165.6 | 202.0 | 171.5 | 150.2 | 143.2 | 146.6 | 207.7 | 177.5 | 189.0 | 141.9 |
| Cost of Revenues | 206.2 | 208.7 | 268.2 | 184.7 | 262.0 | 204.0 | 154.5 | 189.3 | 166.1 | 146.8 | 131.6 | 142.5 | 170.5 | 159.2 | 198.0 | 137.2 |
| Gross Profit | 23.9 | (0.8) | (0.6) | 2.0 | (5.5) | 7.9 | 11.0 | 12.7 | 5.4 | 3.4 | 11.6 | 4.2 | 37.1 | 18.3 | (8.9) | 4.6 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 35.5 | 36.5 | 39.8 | 39.4 | 28.7 | 23.7 | 16.9 | 17.4 | 16.1 | 13.2 | 12.0 | 12.4 | 12.6 | 15.3 | 11.6 | 8.6 |
| R&D Expenses | — | — | — | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 2.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.6 | 0.6 |
| Other Operating Expenses, Total | — | — | — | — | — | — | 0.5 | (0.8) | (1.2) | 0.3 | — | — | — | — | — | — |
| Operating Income | (11.6) | (37.2) | (40.4) | (37.4) | (34.4) | (15.8) | (6.1) | (4.9) | (10.9) | (12.2) | (0.8) | (8.6) | 24.1 | 2.5 | (21.2) | (4.5) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | 58.1 | 52.9 | 46.6 | 39.5 | 28.8 | 24.1 | 22.9 | 21.1 | 25.7 | 19.3 | — | 10.2 | 10.1 | 11.8 | 17.7 | 13.6 |
| EBT, Incl. Unusual Items | (71.7) | (95.7) | (98.4) | (100.2) | (106.7) | (47.3) | (37.6) | (38.3) | (36.3) | (31.8) | (15.6) | (27.1) | 7.1 | (24.4) | (5.4) | (18.4) |
| Income Tax Expense | — | (18.7) | (10.8) | (53.7) | 1.1 | (0.1) | (1.0) | 1.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | (1.1) | (0.1) |
| Net Income | ||||||||||||||||
| Minority Interest | — | — | — | — | — | 0.0 | 0.0 | (3.8) | (3.3) | (1.5) | — | — | — | — | — | — |
| Net Income | (60.2) | (77.0) | (87.5) | (46.4) | (107.8) | (47.1) | (36.7) | (39.5) | (36.3) | (31.8) | (15.6) | (27.1) | 7.1 | (24.4) | (4.3) | (18.3) |
| Per Share | ||||||||||||||||
| Basic EPS | (0.85) | (1.28) | (1.91) | (1.22) | (3.12) | (1.54) | (1.74) | (1.75) | (1.63) | (1.53) | (0.79) | (1.37) | 0.35 | — | — | — |
| Diluted EPS | (0.85) | (1.28) | (1.91) | (1.22) | (3.12) | (1.54) | (1.74) | (1.75) | (1.63) | (1.53) | (0.79) | (1.37) | 0.34 | — | — | — |
| Revenue per Share | 3.10 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 70.9 | 60.0 | 45.9 | 38.1 | 34.6 | 30.7 | 21.0 | 20.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 103.5 |
| Diluted Weighted Avg Shares | 70.9 | 60.0 | 45.9 | 38.1 | 34.6 | 30.7 | 21.0 | 20.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | (27.6) | — | — | — | (10.4) | (1.2) | — | — | — | — | — | — | 7.1 | (18.1) | (3.4) |
| EBIT | (11.6) | (37.2) | (40.4) | (37.4) | (34.4) | (15.8) | (6.1) | (4.9) | (10.9) | (12.2) | (0.8) | (8.6) | 24.1 | 2.5 | (21.2) | (4.5) |
| Effective Tax Rate | — | — | — | 53.7% | -1.0% | 0.3% | 2.6% | -2.9% | -0.0% | -0.0% | -0.0% | -0.0% | 0.1% | -0.0% | 20.2% | 0.5% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.